已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group

医学 心脏病学 内科学 左束支阻滞 铅(地质) 心力衰竭 捆绑 复合材料 材料科学 地质学 地貌学
作者
Pugazhendhi Vijayaraman,Bengt Herweg,Atul Verma,Parikshit S. Sharma,Syeda Atiqa Batul,Shunmuga Sundaram Ponnusamy,Robert D. Schaller,Óscar Cano,Manuel Molina‐Lerma,Karol Čurila,Wim Huybrechts,David R. Wilson,Leonard M. Rademakers,Praveen Sreekumar,Gaurav A. Upadhyay,Kevin Vernooy,Faiz A. Subzposh,Weijian Huang,Marek Jastrzębski,Kenneth A. Ellenbogen
出处
期刊:Heart Rhythm [Elsevier]
卷期号:19 (8): 1272-1280 被引量:68
标识
DOI:10.1016/j.hrthm.2022.04.024
摘要

Background Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is effective in patients with heart failure, left bundle branch block (LBBB), and reduced left ventricular function. Left bundle branch area pacing (LBBAP) has been reported as an alternative option for CRT. Objective The purpose of this study was to assess the feasibility and outcomes of LBBAP in patients who failed conventional BVP because of coronary venous (CV) lead complications or who were nonresponders to BVP. Methods At 16 international centers, LBBAP was attempted in patients with conventional CRT indication who failed BVP because of CV lead complications or lack of therapeutic response to BVP. Heart failure hospitalization (HFH) and death, echocardiographic outcomes, procedural data, pacing parameters, and lead complications including CV lead failure are reported. Results LBBAP was successfully performed in 200 patients (CV lead failures 156; nonresponders 44) (age 68 ± 11 years; female 35%; LBBB 55%; right ventricular pacing 23%; ischemic cardiomyopathy 28%; nonischemic cardiomyopathy 63%; left ventricular ejection fraction [LVEF] ≤35% in 80%). Procedural duration was 119.5 ± 59.6 minutes, and fluoroscopy duration was 25.7 ± 18.5 minutes. LBBAP threshold and R-wave amplitudes were 0.68 ± 0.35 V @ 0.45 ms and 10.4 ± 5 mV at implant, respectively, and remained stable during mean follow-up of 12 ± 10.1 months. LBBAP resulted in significant QRS narrowing from 170 ± 28 ms to 139 ± 25 ms (P <.001) with V6 R-wave peak times of 85 ± 17 ms. LVEF improved from 29% ± 10% at baseline to 40% ± 12% (P <.001) during follow-up. The risk of death or HFH was lower in those with CV lead failure than in nonresponders (hazard ratio 0.357; 95% confidence interval 0.168–0.756; P = .007) Conclusion LBBAP is a viable alternative to CRT in patients who failed conventional BVP due to CV lead failure or who were nonresponders. Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is effective in patients with heart failure, left bundle branch block (LBBB), and reduced left ventricular function. Left bundle branch area pacing (LBBAP) has been reported as an alternative option for CRT. The purpose of this study was to assess the feasibility and outcomes of LBBAP in patients who failed conventional BVP because of coronary venous (CV) lead complications or who were nonresponders to BVP. At 16 international centers, LBBAP was attempted in patients with conventional CRT indication who failed BVP because of CV lead complications or lack of therapeutic response to BVP. Heart failure hospitalization (HFH) and death, echocardiographic outcomes, procedural data, pacing parameters, and lead complications including CV lead failure are reported. LBBAP was successfully performed in 200 patients (CV lead failures 156; nonresponders 44) (age 68 ± 11 years; female 35%; LBBB 55%; right ventricular pacing 23%; ischemic cardiomyopathy 28%; nonischemic cardiomyopathy 63%; left ventricular ejection fraction [LVEF] ≤35% in 80%). Procedural duration was 119.5 ± 59.6 minutes, and fluoroscopy duration was 25.7 ± 18.5 minutes. LBBAP threshold and R-wave amplitudes were 0.68 ± 0.35 V @ 0.45 ms and 10.4 ± 5 mV at implant, respectively, and remained stable during mean follow-up of 12 ± 10.1 months. LBBAP resulted in significant QRS narrowing from 170 ± 28 ms to 139 ± 25 ms (P <.001) with V6 R-wave peak times of 85 ± 17 ms. LVEF improved from 29% ± 10% at baseline to 40% ± 12% (P <.001) during follow-up. The risk of death or HFH was lower in those with CV lead failure than in nonresponders (hazard ratio 0.357; 95% confidence interval 0.168–0.756; P = .007) LBBAP is a viable alternative to CRT in patients who failed conventional BVP due to CV lead failure or who were nonresponders.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
自由的无色完成签到 ,获得积分10
1秒前
4秒前
罗零完成签到 ,获得积分10
9秒前
陈展峰完成签到,获得积分20
11秒前
陈展峰发布了新的文献求助80
15秒前
nnetth完成签到 ,获得积分10
15秒前
悉一完成签到,获得积分10
16秒前
18秒前
18秒前
20秒前
涛哥来科研完成签到 ,获得积分10
21秒前
田柾国发布了新的文献求助10
24秒前
康康完成签到,获得积分10
26秒前
Luke完成签到,获得积分10
27秒前
xianglingliwei完成签到 ,获得积分0
28秒前
Luke发布了新的文献求助10
29秒前
34秒前
包容绿海完成签到,获得积分10
48秒前
51秒前
和谐续完成签到 ,获得积分10
51秒前
短巷完成签到 ,获得积分10
52秒前
默默的阑悦完成签到,获得积分10
52秒前
Nefelibata完成签到,获得积分10
54秒前
小娜娜发布了新的文献求助10
54秒前
杀殿完成签到 ,获得积分10
55秒前
56秒前
z_rainbow完成签到,获得积分10
56秒前
爆米花应助清蒸小朋友采纳,获得10
58秒前
林水程发布了新的文献求助10
59秒前
tszjw168完成签到 ,获得积分10
1分钟前
易玉燕发布了新的文献求助10
1分钟前
花花521完成签到,获得积分10
1分钟前
洪亮完成签到,获得积分10
1分钟前
Limerencia完成签到,获得积分10
1分钟前
情怀应助易玉燕采纳,获得10
1分钟前
mixcom完成签到,获得积分10
1分钟前
陈展峰发布了新的文献求助80
1分钟前
郎治宇完成签到,获得积分10
1分钟前
光亮如彤完成签到,获得积分10
1分钟前
乌龙掌柜完成签到 ,获得积分10
1分钟前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3162208
求助须知:如何正确求助?哪些是违规求助? 2813263
关于积分的说明 7899460
捐赠科研通 2472489
什么是DOI,文献DOI怎么找? 1316444
科研通“疑难数据库(出版商)”最低求助积分说明 631317
版权声明 602142